vs

Side-by-side financial comparison of LIVEPERSON INC (LPSN) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $59.3M, roughly 1.3× LIVEPERSON INC). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -19.0%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-12.0M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -16.6%).

LivePerson is a global technology company that develops conversational commerce and AI software.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

LPSN vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.3× larger
PBYI
$75.5M
$59.3M
LPSN
Growing faster (revenue YoY)
PBYI
PBYI
+46.7% gap
PBYI
27.7%
-19.0%
LPSN
More free cash flow
PBYI
PBYI
$26.3M more FCF
PBYI
$14.4M
$-12.0M
LPSN
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-16.6%
LPSN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LPSN
LPSN
PBYI
PBYI
Revenue
$59.3M
$75.5M
Net Profit
$-46.1M
Gross Margin
73.2%
69.3%
Operating Margin
-68.7%
22.7%
Net Margin
-77.8%
Revenue YoY
-19.0%
27.7%
Net Profit YoY
58.9%
EPS (diluted)
$-9.22
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LPSN
LPSN
PBYI
PBYI
Q4 25
$59.3M
$75.5M
Q3 25
$60.2M
$54.5M
Q2 25
$59.6M
$52.4M
Q1 25
$64.7M
$46.0M
Q4 24
$73.2M
$59.1M
Q3 24
$74.2M
$80.5M
Q2 24
$79.9M
$47.1M
Q1 24
$85.1M
$43.8M
Net Profit
LPSN
LPSN
PBYI
PBYI
Q4 25
$-46.1M
Q3 25
$8.7M
$8.8M
Q2 25
$-15.7M
$5.9M
Q1 25
$-14.1M
$3.0M
Q4 24
$-112.1M
Q3 24
$-28.3M
$20.3M
Q2 24
$41.8M
$-4.5M
Q1 24
$-35.6M
$-4.8M
Gross Margin
LPSN
LPSN
PBYI
PBYI
Q4 25
73.2%
69.3%
Q3 25
71.4%
77.7%
Q2 25
69.7%
76.5%
Q1 25
71.8%
77.1%
Q4 24
77.4%
76.4%
Q3 24
73.1%
63.9%
Q2 24
79.4%
77.4%
Q1 24
71.3%
75.5%
Operating Margin
LPSN
LPSN
PBYI
PBYI
Q4 25
-68.7%
22.7%
Q3 25
-24.2%
17.6%
Q2 25
-10.8%
12.7%
Q1 25
-26.2%
8.7%
Q4 24
-138.0%
22.6%
Q3 24
-21.6%
27.4%
Q2 24
-37.3%
-4.6%
Q1 24
-42.7%
-5.3%
Net Margin
LPSN
LPSN
PBYI
PBYI
Q4 25
-77.8%
Q3 25
14.5%
16.2%
Q2 25
-26.4%
11.2%
Q1 25
-21.8%
6.5%
Q4 24
-153.2%
Q3 24
-38.1%
25.2%
Q2 24
52.3%
-9.6%
Q1 24
-41.8%
-11.0%
EPS (diluted)
LPSN
LPSN
PBYI
PBYI
Q4 25
$-9.22
$0.26
Q3 25
$-2.76
$0.17
Q2 25
$-0.17
$0.12
Q1 25
$-0.24
$0.06
Q4 24
$-17.23
$0.40
Q3 24
$-4.74
$0.41
Q2 24
$-0.33
$-0.09
Q1 24
$-0.40
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LPSN
LPSN
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$95.0M
$97.5M
Total DebtLower is stronger
$22.7M
Stockholders' EquityBook value
$-44.5M
$130.3M
Total Assets
$454.7M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LPSN
LPSN
PBYI
PBYI
Q4 25
$95.0M
$97.5M
Q3 25
$106.7M
$94.4M
Q2 25
$162.0M
$96.0M
Q1 25
$176.3M
$93.2M
Q4 24
$183.2M
$101.0M
Q3 24
$142.1M
$96.7M
Q2 24
$146.0M
$96.8M
Q1 24
$127.1M
$107.2M
Total Debt
LPSN
LPSN
PBYI
PBYI
Q4 25
$22.7M
Q3 25
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$512.1M
$102.0M
Stockholders' Equity
LPSN
LPSN
PBYI
PBYI
Q4 25
$-44.5M
$130.3M
Q3 25
$-22.1M
$115.3M
Q2 25
$-82.4M
$104.7M
Q1 25
$-74.9M
$97.1M
Q4 24
$-67.3M
$92.1M
Q3 24
$45.9M
$71.1M
Q2 24
$66.6M
$48.5M
Q1 24
$19.2M
$51.0M
Total Assets
LPSN
LPSN
PBYI
PBYI
Q4 25
$454.7M
$216.3M
Q3 25
$511.4M
$202.9M
Q2 25
$604.2M
$194.9M
Q1 25
$596.2M
$196.2M
Q4 24
$607.8M
$213.3M
Q3 24
$692.0M
$220.7M
Q2 24
$703.8M
$205.0M
Q1 24
$724.7M
$214.1M
Debt / Equity
LPSN
LPSN
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
26.69×
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LPSN
LPSN
PBYI
PBYI
Operating Cash FlowLast quarter
$-9.7M
$14.4M
Free Cash FlowOCF − Capex
$-12.0M
$14.4M
FCF MarginFCF / Revenue
-20.2%
19.1%
Capex IntensityCapex / Revenue
3.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LPSN
LPSN
PBYI
PBYI
Q4 25
$-9.7M
$14.4M
Q3 25
$-6.0M
$9.7M
Q2 25
$-11.7M
$14.1M
Q1 25
$-3.1M
$3.6M
Q4 24
$-3.1M
$15.6M
Q3 24
$4.8M
$11.0M
Q2 24
$-17.9M
$1.0M
Q1 24
$1.1M
$11.2M
Free Cash Flow
LPSN
LPSN
PBYI
PBYI
Q4 25
$-12.0M
$14.4M
Q3 25
$-8.9M
$9.7M
Q2 25
$-14.8M
$14.1M
Q1 25
$-6.9M
$3.6M
Q4 24
$-6.8M
$15.6M
Q3 24
$-230.0K
$11.0M
Q2 24
$-22.9M
$1.0M
Q1 24
$-10.4M
FCF Margin
LPSN
LPSN
PBYI
PBYI
Q4 25
-20.2%
19.1%
Q3 25
-14.8%
17.7%
Q2 25
-24.9%
26.8%
Q1 25
-10.6%
7.7%
Q4 24
-9.2%
26.4%
Q3 24
-0.3%
13.7%
Q2 24
-28.7%
2.1%
Q1 24
-12.2%
Capex Intensity
LPSN
LPSN
PBYI
PBYI
Q4 25
3.9%
0.0%
Q3 25
4.8%
0.0%
Q2 25
5.3%
0.0%
Q1 25
5.8%
0.1%
Q4 24
5.0%
0.0%
Q3 24
6.8%
0.0%
Q2 24
6.2%
0.0%
Q1 24
13.5%
0.0%
Cash Conversion
LPSN
LPSN
PBYI
PBYI
Q4 25
Q3 25
-0.69×
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
-0.43×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

LPSN
LPSN

Hosted Services Business$51.0M86%
Professional Services$8.3M14%

PBYI
PBYI

Segment breakdown not available.

Related Comparisons